Osteofibrous Dysplasia (Kempson-Campanacci's Disease) (DOFOL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04104763|
Recruitment Status : Recruiting
First Posted : September 26, 2019
Last Update Posted : January 22, 2020
|Condition or disease||Intervention/treatment|
|Osteofibrous Dysplasia||Behavioral: study of osteofibrous dysplasia features|
|Study Type :||Observational|
|Estimated Enrollment :||55 participants|
|Official Title:||Osteofibrous Dysplasia (Kempson-Campanacci's Disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship With Adamantinoma|
|Actual Study Start Date :||August 8, 2019|
|Actual Primary Completion Date :||November 30, 2019|
|Estimated Study Completion Date :||April 30, 2020|
- Behavioral: study of osteofibrous dysplasia features
obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.
- Osteofibrous Dysplasia (Kempson-Campanacci's disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship with Adamantinoma [ Time Frame: BASELINE ]
We will retrieve from the database of the Rizzoli institute all the cases with a histological diagnosis of Ewing sarcoma from 01 Jan 1943 to 31 Dic 2011.
We aspect to find approximately 55 cases. We will review all the medical records, radiological imaging, and histological data of these cases.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04104763
|Contact: ALBERTO RIGHI, MD PhD||+39-051-636 ext email@example.com|
|Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli||Recruiting|
|Bologna, Italy, 40136|
|Contact: Alberto Righi, MD +39051.63.66 ext 665 firstname.lastname@example.org|